Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing
interstitial pneumonia of unknown cause that leads to respiratory failure and death within …
interstitial pneumonia of unknown cause that leads to respiratory failure and death within …
Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know
F Ciccarese, D Attinà, M Zompatori - La radiologia medica, 2016 - Springer
Combined pulmonary fibrosis and emphysema is a relatively newly defined entity, which has
been deeply studied in the recent years. Despite the wide numbers of papers on this topic …
been deeply studied in the recent years. Despite the wide numbers of papers on this topic …
Pulmonary hypertension in childhood interstitial lung disease: a systematic review of the literature
S Bromley, D Vizcaya - Pediatric Pulmonology, 2017 - Wiley Online Library
Childhood interstitial lung disease (chILD) comprises a wide heterogeneous group of rare
parenchymal lung disorders associated with substantial morbidity and mortality. Pulmonary …
parenchymal lung disorders associated with substantial morbidity and mortality. Pulmonary …
[HTML][HTML] Improving the management of patients with chronic cardiac and respiratory diseases by extending pulse-oximeter uses: the dynamic pulse-oximetry
S Nardini, U Corbanese, A Visconti… - Multidisciplinary …, 2023 - ncbi.nlm.nih.gov
Respiratory and cardio-vascular chronic diseases are among the most common
noncommunicable diseases (NCDs) worldwide, accounting for a large portion of health-care …
noncommunicable diseases (NCDs) worldwide, accounting for a large portion of health-care …
Identifying patients with group 3 pulmonary hypertension associated with COPD or ILD using an administrative claims database
GA Heresi, BB Dean, H Castillo, HF Lee, P Classi… - Lung, 2022 - Springer
Background Group 3 pulmonary hypertension (PH) describes a subpopulation of patients
with PH due to chronic lung disease and/or hypoxia, with chronic obstructive pulmonary …
with PH due to chronic lung disease and/or hypoxia, with chronic obstructive pulmonary …
Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with …
R Parikh, A Thomas, A Sharofi, N Moallem… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Pulmonary hypertension (PH) leads to increased morbidity and mortality in
interstitial lung disease (ILD). While the INCREASE trial highlighted the use of inhaled …
interstitial lung disease (ILD). While the INCREASE trial highlighted the use of inhaled …
Severe PH-ILD presenting as RV failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin
R Parikh, A Thomas, A Sharofi, N Moallem… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Pulmonary hypertension (PH) worsens the morbidity and mortality in interstitial
lung disease (ILD). While the INCREASE trial highlighted the use of inhaled prostacyclin in …
lung disease (ILD). While the INCREASE trial highlighted the use of inhaled prostacyclin in …
Pulmonary hypertension in interstitial lung disease: a systematic review and meta-analysis
HL Ang, M Schulte, RK Chan, HH Tan, A Harrison… - Chest, 2024 - Elsevier
Background Pulmonary hypertension (PH) is a key complication in interstitial lung disease
(ILD), with recent therapeutic advances. Research question What are the diagnostic …
(ILD), with recent therapeutic advances. Research question What are the diagnostic …
A PrOsPective Cohort Study on Interstitial Lung Disease-Associated Pulmonary Hypertension with a ParticulaR Focus on the Subset with Pulmonary Arterial …
I Tsujino, K Kitahara, J Omura, T Iwahori, S Konno - Pulmonary Therapy, 2024 - Springer
Introduction The pathogenesis and clinical profiles of patients with pulmonary hypertension
(PH) associated with interstitial lung disease (ILD-PH) are poorly understood. Whether and …
(PH) associated with interstitial lung disease (ILD-PH) are poorly understood. Whether and …
Multidisciplinary care and prognosis in patients with COPD and interstitial lung disease prescribed long-term oxygen therapy
ACA Harrison, JF Robinson, L Tu, CF McDonald… - Respiratory …, 2022 - rc.rcjournal.com
BACKGROUND: Home oxygen therapy is prescribed for patients with advanced lung
disease based on the criteria established in landmark trials in subjects with COPD. In clinical …
disease based on the criteria established in landmark trials in subjects with COPD. In clinical …